Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Public health departments are now being told to prepare to distribute COVID-19 vaccines as early as November 1.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
While research is underway to develop new therapies for fatty liver disease, here are steps you can take to keep your liver healthy.
Some study participants experienced hepatitis B surface antigen loss, considered a functional cure.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
People who received the vaccine did, however, show stronger immune responses against the virus.
The social media platform will use pop-ups to educate users about vaccines with info from credible health agencies.
What do you know about hepatitis E?
An outbreak has prompted a mass vaccination effort.
CDC experts recommend the vaccine for children, teens and HIV-positive people.
Human psychology and social media may be to blame for the spread of negative attitudes toward vaccines.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.